Patent Trial + Appeal Board

Litigation in the pharmaceutical and biotechnology industry can be particularly complex, requiring counsel that is as well versed across scientific disciplines as it is in the law. Goodwin has made servicing the needs of the pharmaceutical and biotechnology industries a strategic priority for more than two decades, and we have one of the largest and most active life sciences practices in the United States. Our IP litigation team is among the most experienced in the country, successfully representing both brand companies and generics in Hatch-Waxman litigation. Our portfolio of clients include the largest generic companies in the world and, more recently, include enforcement of patents related to numerous blockbuster drugs.

Our firm is also a leader in the emerging field of biosimilars litigation. Our lawyers were involved in the legislative process that resulted in the Biologics Price Competition and Innovation Act, and our work counseling clients as they advance their biosimilar development programs has been a natural outgrowth of our extensive work on behalf of the generic drug industry. Clients consistently praise our biosimilars blog, BigMoleculeWatch.com, for its timely and relevant posts on biosimilar-related litigation, legislation and regulatory developments.

Companies with Section 337 investigations at the U.S. International Trade Commission know the stakes are high and having experienced counsel is critical. Goodwin’s ITC team has substantial knowledge of complex investigations under Section 337 and has a winning track record. We represent U.S. and international clients on both sides of disputes involving patents, trademarks, copyrights and trade secrets. Our team can quickly initiate investigations and swiftly respond to new investigations, protecting clients’ products and industries.

Our ITC lawyers have first-chair experience before the ITC and know exactly how to prepare matters for trial quickly and efficiently. Our practice chair is a former ITC attorney with firsthand knowledge of the Commission’s culture. Additionally, we are adept in delivering persuasive presentations under the judges’ diverse approaches to ITC trials. A win in high-stakes ITC litigation is only as good as the remedy, and Goodwin has extensive experience dealing with U.S. Customs and the Court of International Trade on enforcement matters.

In a high-stakes patent dispute, the fighting advantage goes to the side with the right litigation experience. We’re ranked by Corporate Counsel as having one of the nation’s most active patent litigation practices. From the courtroom to the boardroom, Goodwin’s more than 100 IP lawyers and scientists are dedicated to actively protecting client assets.